Xenon Pharmaceuticals Inc (XENE)
Healthcare
Biotechnology
62.30 $
-0.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Xenon Pharmaceuticals Inc (XENE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -279 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.3 | -18 | -20 | -29 | -35 | -4.6 | -48 | -70 | -98 | -145 | -181 | -279 | |
| 0.7 | 1.0 | 0.9 | 0.6 | 0.6 | 0.4 | 0.6 | 0.9 | 1.6 | 3.5 | 2.6 | 2.5 | |
| 0.8 | 3.7 | 2.2 | 2.2 | 2.6 | 2.9 | 5.7 | 10 | 20 | 32 | 51 | 54 | |
| 0.8 | 11 | 0.8 | 0.8 | -1.1 | 2.5 | 5.9 | 11 | 23 | – | – | – | |
| -14 | -14 | 1.8 | 0.6 | 0.0 | 34 | -26 | -2.6 | -0.7 | 5.6 | 5.7 | 4.4 | |
| 1.5 | 0.6 | 0.3 | 0.3 | 0.5 | 1.2 | 2.6 | 2.1 | 2.9 | 5.6 | 3.1 | 0.8 | |
| -3.2 | 10 | -48 | 24 | -29 | -66 | -17 | -247 | -296 | -117 | 165 | 218 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 43 | 0.3 | 24 | 0.2 | 103 | 28 | 103 | 0.3 | 0.7 | – | – | – | |
| 6.9 | 6.9 | 6.9 | 6.9 | 8.5 | -17 | -17 | 0.0 | 0.0 | – | – | – | |
| 41 | 0.3 | 24 | 7.1 | 112 | 28 | 86 | 448 | 278 | 354 | 12 | 117 | |
| 34 | -13 | -42 | 3.4 | 47 | -43 | 20 | 131 | -118 | 91 | -5.9 | 56 | |
| -1.3 | -19 | -20 | -29 | -35 | -5.9 | -51 | -72 | -101 | -151 | -184 | -280 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.